Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-01 in Irritable Bowel Syndrome
NCT04598295Phase 2Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Oct 2020
- Primary completion
- Oct 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of DS-01 in irritable bowel syndrome (IBS), sponsored by Beth Israel Deaconess Medical Center. Started Oct 2020; status: completed.
02
Drugs
DS-01
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04598295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598295.